abrdn Healthcare Investors (NYSE:HQH) Short Interest Update

abrdn Healthcare Investors (NYSE:HQH) was the recipient of a significant drop in short interest during the month of August. As of August 31st, there was short interest totaling 82,667 shares, a drop of 39.7% from the August 15th total of 137,144 shares. Based on an average trading volume of 219,445 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.2% of the company’s shares are short sold.

abrdn Healthcare Investors Price Performance

HQH stock traded up $0.07 during trading on Wednesday, reaching $21.46. 97,980 shares of the stock traded hands, compared to its average volume of 187,368. The business’s 50 day moving average price is $22.39 and its 200-day moving average price is $20.46. abrdn Healthcare Investors has a 52-week low of $16.43 and a 52-week high of $24.85.

abrdn Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Monday, August 24th will be issued a dividend of $0.66 per share. The ex-dividend date is Monday, August 24th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 12.3%.

Institutional Trading of abrdn Healthcare Investors

Institutional investors and hedge funds have recently bought and sold shares of the business. Integrated Wealth Concepts LLC acquired a new position in abrdn Healthcare Investors during the second quarter valued at approximately $149,000. NewEdge Advisors LLC grew its stake in abrdn Healthcare Investors by 8.4% during the second quarter. NewEdge Advisors LLC now owns 164,510 shares of the financial services provider’s stock worth $3,616,000 after buying an additional 12,772 shares during the period. Ameritas Advisory Services LLC acquired a new stake in shares of abrdn Healthcare Investors in the second quarter worth $149,000. Turner Financial Group Inc. acquired a new stake in shares of abrdn Healthcare Investors in the second quarter worth $388,000. Finally, Triumph Capital Management raised its stake in shares of abrdn Healthcare Investors by 1.3% in the 2nd quarter. Triumph Capital Management now owns 45,512 shares of the financial services provider’s stock valued at $1,000,000 after acquiring an additional 567 shares during the period. Institutional investors and hedge funds own 32.60% of the company’s stock.

abrdn Healthcare Investors Company Profile

abrdn Healthcare Investors (NYSE: HQH) is a non-diversified, closed-end investment company focused on the healthcare and life sciences sectors. The fund seeks long-term capital appreciation by investing in a portfolio of public and private companies involved in areas such as biotechnology, pharmaceuticals, medical devices, healthcare services and other related industries.

The fund invests primarily in equity securities, including common stocks and other securities of healthcare companies at various stages of development.